• Users Online: 204
  • Home
  • Print this page
  • Email this page
Home Current issue Ahead of print Search About us Abstracting and Indexing Editorial board Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Neuroprotection in glaucoma

Doozandeh Azadeh, Yazdani Shahin

Year : 2016| Volume: 11| Issue : 2 | Page no: 209-220

   This article has been cited by
1 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Lei Gu,Jacky M.K. Kwong,Daniel Yadegari,Fei Yu,Joseph Caprioli,Natik Piri
Neuroscience Letters. 2018; 670: 89
[Pubmed]  [Google Scholar] [DOI]
2 Recent advances in the management and understanding of macular degeneration
Sepehr Bahadorani,Michael Singer
F1000Research. 2017; 6: 519
[Pubmed]  [Google Scholar] [DOI]
3 Rolle des alternden visuellen Systems bei Glaukomen
J. D. Unterlauft,M. R. R. Böhm
Der Ophthalmologe. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
Carol B. Toris,Claire Gelfman,Andy Whitlock,William E. Sponsel,Cheryl L. Rowe-Rendleman
Journal of Ocular Pharmacology and Therapeutics. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy
Charles McMonnies
Journal of Optometry. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation
Jed Asher Lusthaus,Ivan Goldberg
Expert Opinion on Drug Safety. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
7 Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Paul Harasymowycz,Catherine Birt,Patrick Gooi,Lisa Heckler,Cindy Hutnik,Delan Jinapriya,Lesya Shuba,David Yan,Radmila Day
Journal of Ophthalmology. 2016; 2016: 1
[Pubmed]  [Google Scholar] [DOI]


Read this article